Table 2.

¹H MRS findings.

		Schizophrenia (n=30)	Bipolar Disorder (n=28)	Healthy Controls (n=30)	F	p
Left Hemisphere
Glu		0.00088 ± 0.00011	0.00082 ± 0.00010	0.00095 ± 0.00013	F(2,78)=8.52	<0.0001
Covariates: (related to disorder)	age onset				F(1,50)=4.39	0.041
	duration				F(1,50)=4.64	0.036
	CPZE				F(1,36)=5.78	0.021
tNAA		0.00111 ± 0.00016	0.00104 ± 0.00015	0.00117 ± 0.00013	F(2,81)=5.73	0.005
Covariates: (related to disorder)	age onset				F(1,52)=3.53	0.066
	duration				F(1,52)=3.73	0.059
	CPZE				F(1,36)=2.83	0.101
tCr		0.00080 ± 0.00011	0.00071 ± 0.00011	0.00080 ± 0.00011	F(2,83)=5.91	0.004
Covariates: (related to disorder)	age onset				F(1,52)=8.91	0.004
	duration				F(1,52)=7.26	0.009
	CPZE				F(1,36)=6.40	0.016
Ins		0.00067 ± 0.00010	0.00057 ± 0.00012	0.00067 ± 0.00011	F(2,82)=8.49	<0.0001
Covariates: (related to disorder)	age onset				F(1,52)=14.48	<0.0001
	duration				F(1,52)=11.25	0.001
	CPZE				F(1,35)=6.64	0.014

Absolute quantity averages are reported with standard deviations. Univariate ANOVA. CPZE: chlorpromazine Equivalent.